Combination strategies with checkpoint immunotherapy and inducers of immunogenic cell death (ICD) in immune competent syngeneic models

被引：0
|
作者：
McKenzie, A. [1 ]
Papadopoulou, N. [1 ]
Yin, Y. [1 ]
Jiang, S. [1 ]
Wrigley, J. [2 ]
King, J. [3 ]
Garland, R. [4 ]
Williams, N. [5 ]
Kumari, R. [6 ]
机构：
[1] Crown Biosci UK Ltd, Sci Operat, Loughborough, Leics, England
[2] Crown Biosci UK Ltd, Vitro Operat, Loughborough, Leics, England
[3] Crown Biosci UK Ltd, Vivo Operat, Loughborough, Leics, England
[4] KWS Biotest, Analyt Serv, Bristol, Avon, England
[5] KWS Biotest, Bristol, Avon, England
[6] Crown Biosci UK Ltd, CBUK, Loughborough, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32931-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
338
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [1] Immune competent syngeneic models demonstrate additive effects of combination strategies using checkpoint immunotherapy and inducers of immunogenic cell death (ICD)
    Mckenzie, Andrew
    Kumari, Rajendra
    Shi, Qian
    Papadopoulou, Nektaria
    Yin, Yinfei
    Jiang, Simon
    Wrigley, Jane
    King, Jason
    Williams, Neil
    Garland, Russell
    CANCER RESEARCH, 2016, 76
  • [2] Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
    Qi, Jing
    Jin, Feiyang
    Xu, Xiaoling
    Du, Yongzhong
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 1435 - 1456
  • [3] Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers
    Shi, Fukang
    Huang, Xing
    Hong, Zhengtao
    Lu, Na
    Huang, Xin
    Liu, Lingyue
    Liang, Tingbo
    Bai, Xueli
    CANCER LETTERS, 2023, 562
  • [4] Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
    Moon, Yujeong
    Cho, Hanhee
    Kim, Kwangmeyung
    PHARMACEUTICS, 2024, 16 (06)
  • [5] The inducers of immunogenic cell death for tumor immunotherapy
    Li, Xiuying
    TUMORI JOURNAL, 2018, 104 (01): : 1 - 8
  • [6] Immunogenic cell death inducers for enhanced cancer immunotherapy
    Li, Yanhua
    Liu, Xiaohan
    Zhang, Xia
    Pan, Wei
    Li, Na
    Tang, Bo
    CHEMICAL COMMUNICATIONS, 2021, 57 (91) : 12087 - 12097
  • [7] Nanomedicine-mediated immunogenic cell death and its combination with immune checkpoint blockade therapy
    CHEN JunBin
    ZHANG YuXi
    SU Miao
    ZHU YueQiang
    YANG XianZhu
    ScienceChina(TechnologicalSciences), 2024, 67 (08) : 2350 - 2362
  • [8] Nanomedicine-mediated immunogenic cell death and its combination with immune checkpoint blockade therapy
    Chen, JunBin
    Zhang, YuXi
    Su, Miao
    Zhu, YueQiang
    Yang, XianZhu
    SCIENCE CHINA-TECHNOLOGICAL SCIENCES, 2024, 67 (08) : 2350 - 2362
  • [9] Mechanisms of immunogenic cell death and immune checkpoint blockade therapy
    Lin, Richard A.
    Lin, Jessica K.
    Lin, Shiaw-Yih
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2021, 37 (06): : 448 - 458
  • [10] Characterization of OVA-expressing immunogenic syngeneic tumor models for immune checkpoint inhibitor evaluation
    Nie, Chenpan
    Zhang, Yi
    Zheng, Jia
    An, Annie X.
    Zhou, Jun
    Li, Henry Q. X.
    Wang, Jingjing
    CANCER RESEARCH, 2022, 82 (12)
12345